Apply for XELODA (CAPECITABINE) patient assistance or copay help now

We believe that high deductibles and copays shouldn’t prevent anyone from receiving the medications they need. That’s why at QuickRx, we offer a Xeloda (Capecitabine) Copay Assistance Program. This is designed to help patients reduce their copays and out-of-pocket costs for their medication. Our program partners with various foundations and manufacturer assistance programs to help make a patient’s medication affordable.

Xeloda (Capecitabine) copay assistance is the term used to define any program that helps eligible patients reduce the cost of their monthly copays. Similar programs exist for a large number of other medications as well.

This can be tricky as there are dozens, perhaps even hundreds of programs out there offering Xeloda patient assistance or Xeloda manufacturing coupons. Finding the right one to meet your qualifications can be tough, and many have told us they had the most trouble figuring out where to go. QuickRx is always standing by to help.

Xeloda (Capecitabine) copay assistance can be delivered in a lot of different ways such as coupons or copay cards. But how does one find it? That’s where our team comes in. These programs can be difficult to sift through, and more difficult to keep up with once your benefits are attained.

With our team of specialists, you won’t have to worry about Xeloda copay assistance or Capecitabine copay assistance ever again. Come to QuickRx, where the primary therapy we dispense is peace of mind.

Here are the ways to apply for the program:

• Fill out the form located above on this page
• Call us at (347)-691-3494 or toll-free at (800)-496-6111.

You can also fill out our Contact Form, and someone will call you back within 1-2 business days.

Capecitabine, which is the generic name for Xeloda, is a chemotherapy drug used to treat the following cancers; Colon or rectal cancer, metastatic breast cancer, esophageal, gastric, hepatobiliary, neuroendocrine, pancreatic, ovarian, fallopian tube, peritoneal, or unknown primary cancers (off-label use)

Capecitabine tablets are available in 2 doses; 150mg and 500mg. Your doctor will determine which dose is right for you after close analysis. 

Xeloda (Capecitabine) belongs to the group of chemotherapy called antimetabolite, which slows or stops the growth of cancer cells that are eventually destroyed by the body.

You should take Xeloda (Capecitabine) 30 minutes after eating and swallow the pill whole with water. Never break, crush, or chew Xeloda (Capecitabine). Your doctor will determine your dosage and schedule. Always follow the orders from your physician or the directions on the medication label.

The brand name for Capecitabine is Xeloda. 

Some common side effects of Capecitabine include, but are not limited to; abdominal/stomach pain, nausea, vomiting, diarrhea, loss of fingerprints, numbness, pain, blistering, peeling, redness, or swelling in the palms of the hands or bottoms of the feet, pain, redness, swelling, sores, or ulcers in the mouth or on the lips, and unusual tiredness or weakness.

Again, this is not a full list of side effects and not everyone will experience all side effects. Each person’s response to a medication differs. If you have questions about these or any other side effects you may be experiencing from this or any other medications our pharmacists can always be reached during business hours to address questions and concerns.

If your side effects are causing a major discomfort it is recommended to call your doctor immediately or proceed to the nearest emergency room if your symptoms are severe.

Xeloda (Capecitabine) is taken orally (by mouth) in pill form. Do not crush, cut, or chew this medication. 

It’s important to take your medication as scheduled. If you miss a dose of Xeloda or Capecitabine, skip the missed dose and continue with your regular dosing schedule. Never take a double dose, or adjust your dosing schedule. If you skip more than one dose contact your doctor or one of our pharmacists to discuss how you should proceed with your next dose.